{"id":"https://openalex.org/W4415723959","doi":"https://doi.org/10.2147/opth.s538141","title":"Expert Opinion to Optimize Clinical Outcomes of Bimatoprost Intracameral Implant Treatment","display_name":"Expert Opinion to Optimize Clinical Outcomes of Bimatoprost Intracameral Implant Treatment","publication_year":2025,"publication_date":"2025-10-01","ids":{"openalex":"https://openalex.org/W4415723959","doi":"https://doi.org/10.2147/opth.s538141","pmid":"https://pubmed.ncbi.nlm.nih.gov/41195297"},"language":"en","primary_location":{"id":"doi:10.2147/opth.s538141","doi":"https://doi.org/10.2147/opth.s538141","is_oa":true,"landing_page_url":"https://doi.org/10.2147/opth.s538141","pdf_url":"https://www.dovepress.com/article/download/108413","source":{"id":"https://openalex.org/S105513329","display_name":"Clinical ophthalmology","issn_l":"1177-5467","issn":["1177-5467","1177-5483"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/article/download/108413","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026279170","display_name":"Courtney E. Bovee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Courtney Bovee","raw_affiliation_strings":["Bovee Eye PLLC, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bovee Eye PLLC, Tampa, FL, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054178666","display_name":"Jason Bacharach","orcid":"https://orcid.org/0000-0002-7084-4327","observed_orcids":["https://orcid.org/0000-0002-7084-4327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Bacharach","raw_affiliation_strings":["North Bay Eye Associates, Inc, Petaluma, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North Bay Eye Associates, Inc, Petaluma, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Inder Singh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Inder Singh","raw_affiliation_strings":["Eye Centers of Racine & Kenosha, Racine, WI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eye Centers of Racine & Kenosha, Racine, WI, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103125603","display_name":"Swarup S. Swaminathan","orcid":"https://orcid.org/0000-0001-7198-6602","observed_orcids":["https://orcid.org/0000-0001-7198-6602"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Swarup Swaminathan","raw_affiliation_strings":["Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035713212","display_name":"Renee Bovelle","orcid":"https://orcid.org/0009-0004-3476-2289","observed_orcids":["https://orcid.org/0009-0004-3476-2289"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renee Bovelle","raw_affiliation_strings":["Envision Eye & Laser Center, Glenn Dale, MD, USA"],"raw_orcid":"https://orcid.org/0009-0004-3476-2289","affiliations":[{"raw_affiliation_string":"Envision Eye & Laser Center, Glenn Dale, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108972559","display_name":"Hongxin Lai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hongxin Lai","raw_affiliation_strings":["AbbVie, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Irvine, CA, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022702564","display_name":"Marcos Rivas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150482","display_name":"AbbVie (Spain)","ror":"https://ror.org/04p6dqe59","country_code":"ES","type":"company","lineage":["https://openalex.org/I2948539688","https://openalex.org/I4210150482"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marcos Rivas","raw_affiliation_strings":["AbbVie, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Madrid, Spain","institution_ids":["https://openalex.org/I4210150482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069816640","display_name":"Vanessa Vera","orcid":"https://orcid.org/0000-0003-2294-0055","observed_orcids":["https://orcid.org/0000-0003-2294-0055"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vanessa Vera","raw_affiliation_strings":["AbbVie, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Irvine, CA, USA","institution_ids":["https://openalex.org/I2948539688"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2320,"currency":"USD","value_usd":2320},"apc_paid":{"value":2320,"currency":"USD","value_usd":2320},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.35307737,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"Volume 19","issue":null,"first_page":"4027","last_page":"4042"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11291","display_name":"Intraocular Surgery and Lenses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intraocular-pressure-reduction","display_name":"intraocular pressure reduction","score":0.6850000023841858},{"id":"https://openalex.org/keywords/ocular-hypertension","display_name":"ocular hypertension","score":0.824999988079071},{"id":"https://openalex.org/keywords/open-angle-glaucoma","display_name":"open-angle glaucoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8410000205039978},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.640999972820282},{"id":"https://openalex.org/keywords/implantation-procedure","display_name":"implantation procedure","score":0.8830000162124634},{"id":"https://openalex.org/keywords/follow-up-management","display_name":"follow-up management","score":0.8489999771118164},{"id":"https://openalex.org/keywords/implant-complications","display_name":"implant complications","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9485999941825867},{"id":"https://openalex.org/C2777336333","wikidata":"https://www.wikidata.org/wiki/Q2393348","display_name":"Bimatoprost","level":4,"score":0.8847000002861023},{"id":"https://openalex.org/C3020580240","wikidata":"https://www.wikidata.org/wiki/Q663272","display_name":"Expert opinion","level":2,"score":0.7756999731063843},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.7050999999046326},{"id":"https://openalex.org/C2779903281","wikidata":"https://www.wikidata.org/wiki/Q6888026","display_name":"Modalities","level":2,"score":0.49540001153945923},{"id":"https://openalex.org/C2776521421","wikidata":"https://www.wikidata.org/wiki/Q9294051","display_name":"Ocular hypertension","level":3,"score":0.48899999260902405},{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.4880000054836273},{"id":"https://openalex.org/C2781411149","wikidata":"https://www.wikidata.org/wiki/Q486975","display_name":"Implant","level":2,"score":0.44670000672340393},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4311000108718872},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.4251999855041504},{"id":"https://openalex.org/C3020606620","wikidata":"https://www.wikidata.org/wiki/Q179661","display_name":"Treatment modality","level":2,"score":0.3801000118255615},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.35920000076293945},{"id":"https://openalex.org/C2780674532","wikidata":"https://www.wikidata.org/wiki/Q3397626","display_name":"Second opinion","level":2,"score":0.3222000002861023},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.31869998574256897},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3183000087738037},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.27399998903274536},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2612000107765198},{"id":"https://openalex.org/C2778073030","wikidata":"https://www.wikidata.org/wiki/Q413994","display_name":"Timolol","level":3,"score":0.2599000036716461},{"id":"https://openalex.org/C19648533","wikidata":"https://www.wikidata.org/wiki/Q691640","display_name":"Evidence-based medicine","level":3,"score":0.25429999828338623}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.2147/opth.s538141","doi":"https://doi.org/10.2147/opth.s538141","is_oa":true,"landing_page_url":"https://doi.org/10.2147/opth.s538141","pdf_url":"https://www.dovepress.com/article/download/108413","source":{"id":"https://openalex.org/S105513329","display_name":"Clinical ophthalmology","issn_l":"1177-5467","issn":["1177-5467","1177-5483"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Ophthalmology","raw_type":"journal-article"},{"id":"pmid:41195297","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41195297","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical ophthalmology (Auckland, N.Z.)","raw_type":"Journal Article"},{"id":"pmh:oai:dovepress.com/108413","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/expert-opinion-to-optimize-clinical-outcomes-of-bimatoprost-intracamer-peer-reviewed-fulltext-article-OPTH","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:europepmc.org:11393869","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12584811","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.2147/opth.s538141","doi":"https://doi.org/10.2147/opth.s538141","is_oa":true,"landing_page_url":"https://doi.org/10.2147/opth.s538141","pdf_url":"https://www.dovepress.com/article/download/108413","source":{"id":"https://openalex.org/S105513329","display_name":"Clinical ophthalmology","issn_l":"1177-5467","issn":["1177-5467","1177-5483"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Ophthalmology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320326336","display_name":"Heidelberg Engineering","ror":"https://ror.org/03thsxs59"},{"id":"https://openalex.org/F4320332585","display_name":"Allergan","ror":"https://ror.org/00wthd003"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415723959.pdf","grobid_xml":"https://content.openalex.org/works/W4415723959.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1988307533","https://openalex.org/W2018333565","https://openalex.org/W2122691108","https://openalex.org/W2128959641","https://openalex.org/W2137349908","https://openalex.org/W2160605010","https://openalex.org/W2561125180","https://openalex.org/W2998106049","https://openalex.org/W3026433768","https://openalex.org/W3034581937","https://openalex.org/W3035027473","https://openalex.org/W3086973890","https://openalex.org/W3103222677","https://openalex.org/W3208090330","https://openalex.org/W3214141958","https://openalex.org/W4281951579","https://openalex.org/W4293795113","https://openalex.org/W4296156579","https://openalex.org/W4309158203","https://openalex.org/W4381250731","https://openalex.org/W4382631585","https://openalex.org/W4385410953","https://openalex.org/W4388281217","https://openalex.org/W4391033002","https://openalex.org/W4392197973","https://openalex.org/W4392985226","https://openalex.org/W4393120132","https://openalex.org/W4393236692","https://openalex.org/W4394806177","https://openalex.org/W4396928699","https://openalex.org/W4399667528","https://openalex.org/W4402172238","https://openalex.org/W4403361988","https://openalex.org/W4405175734","https://openalex.org/W4405599010","https://openalex.org/W4406276589","https://openalex.org/W4406357832","https://openalex.org/W4407430222","https://openalex.org/W4407860527"],"related_works":[],"abstract_inverted_index":{"Achieving":[0],"a":[1,40,95],"target":[2],"intraocular":[3],"pressure":[4],"(IOP)":[5],"in":[6,74,170],"patients":[7,44,171],"with":[8,66,172],"ocular":[9],"hypertension":[10],"and":[11,20,57,69,121,146,183,208,213],"open-angle":[12],"glaucoma":[13,36],"has":[14,139],"many":[15],"barriers,":[16],"some":[17],"treatment":[18,50,98],"specific":[19],"others":[21],"patient":[22,184,198],"specific.":[23],"Nonadherence":[24],"to":[25,34,143,155,195],"IOP-lowering":[26,151],"eyedrops":[27],"is":[28,39,167,194],"one":[29],"of":[30,43,108,117,124,131,137,164,190],"the":[31,88,106,109,122,125,141,147,161,165,180,203],"major":[32],"barriers":[33],"effective":[35],"treatment.":[37],"There":[38],"wide":[41],"range":[42],"who":[45,63,71,127],"may":[46],"benefit":[47,73],"from":[48,76],"non-topical":[49],"modalities":[51],"such":[52],"as":[53],"selective":[54],"laser":[55],"trabeculoplasty":[56],"sustained-release":[58],"drug":[59,81],"delivery,":[60],"including":[61],"those":[62,70],"face":[64],"challenges":[65],"topical":[67,150],"eyedrops,":[68],"find":[72],"independence":[75],"daily":[77],"medication":[78,152],"administration.":[79],"Sustained-release":[80],"delivery":[82],"options":[83],"for":[84,149,153,200],"lowering":[85],"IOP":[86,145],"include":[87],"bimatoprost":[89],"intracameral":[90],"implant":[91,110,166],"10":[92],"\u00b5g":[93],"(Bim-I),":[94],"relatively":[96],"new":[97],"option.":[99],"This":[100],"article":[101],"provides":[102],"expert":[103,192],"opinion":[104,193],"on":[105,112],"use":[107],"based":[111],"available":[113],"literature,":[114],"supplementary":[115],"analysis":[116],"clinical":[118,209],"trial":[119],"data,":[120],"experience":[123],"authors":[126],"have":[128],"performed":[129],"thousands":[130],"Bim-I":[132,138,201],"administrations.":[133],"A":[134],"single":[135],"administration":[136,181],"demonstrated":[140],"potential":[142,215],"reduce":[144],"need":[148],"up":[154],"2":[156],"years.":[157],"Evidence":[158],"suggests":[159],"that":[160],"safety":[162],"profile":[163],"most":[168],"favorable":[169],"wide-open":[173],"(Shaffer":[174],"grade":[175],"4)":[176],"angles.":[177],"Recommendations":[178],"regarding":[179],"procedure":[182],"follow-up":[185,206],"are":[186],"provided.":[187],"The":[188],"objective":[189],"this":[191],"help":[196],"optimize":[197],"selection":[199],"administration,":[202],"implantation":[204],"procedure,":[205],"management,":[207],"outcomes":[210],"while":[211],"minimizing":[212],"addressing":[214],"complications.":[216]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-31T00:00:00"}
